Alfredo Berruti

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 17

Top Topics

Neuroendocrine Tumors

Endoplasmic Reticulum

Clinical Practice

Top Venues

This page only lists publications with an associated author ORCID identifier.

Publications

Elisa Rossini, Mariangela Tamburello, Andrea Abate, Silvia Zini, Giovanni Ribaudo, Alessandra Gianoncelli, Stefano Calza, Francesca Valcamonico, Nazareno R Suardi, Giuseppe Mirabella, Alfredo Berruti, Sandra Sigala
The CDK Inhibitor Dinaciclib Improves Cisplatin Response in Nonseminomatous Testicular Cancer: A Preclinical Study. Cells 13 (5) (2024)
Elisa Rossini, Mariangela Tamburello, Andrea Abate, Silvia Zini, Giovanni Ribaudo, Alessandra Gianoncelli, Stefano Calza, Francesca Valcamonico, Nazareno R Suardi, Giuseppe Mirabella, Alfredo Berruti, Sandra Sigala
The CDK Inhibitor Dinaciclib Improves Cisplatin Response in Nonseminomatous Testicular Cancer: A Preclinical Study. Cells 13 (5) (2024)
Elisa Rossini, Mariangela Tamburello, Andrea Abate, Silvia Zini, Giovanni Ribaudo, Alessandra Gianoncelli, Stefano Calza, Francesca Valcamonico, Nazareno R Suardi, Giuseppe Mirabella, Alfredo Berruti, Sandra Sigala
The CDK Inhibitor Dinaciclib Improves Cisplatin Response in Nonseminomatous Testicular Cancer: A Preclinical Study. Cells 13 (5) (2024)
Mariangela Tamburello, Andrea Abate, Elisa Rossini, Ram Manohar Basnet, Daniela Zizioli, Deborah Cosentini, Constanze Hantel, Marta Laganà, Guido Alberto Massimo Tiberio, Salvatore Grisanti, Maurizio Memo, Alfredo Berruti, Sandra Sigala
Preclinical Evidence of Progesterone as a New Pharmacological Strategy in Human Adrenocortical Carcinoma Cell Lines. International journal of molecular sciences 24 (7) (2023)
Mirco Bartolomei, Alfredo Berruti, Massimo Falconi, Nicola Fazio, Diego Ferone, Secondo Lastoria, Giovanni Luigi Pappagallo, Ettore Seregni, Annibale Versari
Clinical Management of Neuroendocrine Neoplasms in Clinical Practice: A Formal Consensus Exercise. Cancers 14 (10) (2022)
Alfredo Berruti, Vito Amoroso, Rebecca Pedersini
Endocrine and Neuroendocrine Tumors: A Special Issue. Cancers 14 (20) (2022)
Irene Caramella, Alberto Dalla Volta, Marco Bergamini, Deborah Cosentini, Francesca Valcamonico, Alfredo Berruti
Maintenance of androgen deprivation therapy or testosterone supplementation in the management of castration-resistant prostate cancer: that is the question. Endocrine 78 (3) (2022)
Antonella Turla, Marta Laganà, Salvatore Grisanti, Andrea Abate, Vittorio Domenico Ferrari, Valentina Cremaschi, Sandra Sigala, Francesca Consoli, Deborah Cosentini, Alfredo Berruti
Supportive therapies in patients with advanced adrenocortical carcinoma submitted to standard EDP-M regimen. Endocrine 77 (3) (2022)
Deborah Cosentini, Salvatore Grisanti, Marta Laganà, Vittorio Domenico Ferrari, Alberto Dalla Volta, Sandra Sigala, Massimo Terzolo, Alfredo Berruti
Frequency and outcome of SARS-CoV-2 infection in patients with adrenocortical carcinoma followed at a reference center in Italy. Endocrine 72 (1) (2021)
Alfredo Berruti, Guido Alberto Massimo Tiberio, Sandra Sigala
Adrenocortical Carcinoma. Cancers 13 (5) (2021)
Vittoria Basile, Puglisi Soraya, Barbara Altieri, Letizia Canu, Rossella Libè, Filippo Ceccato, Felix Beuschlein, Marcus Quinkler, Anna Calabrese, Paola Perotti, Berchialla Paola, Ulrich Dischinger, Felix Megerle, Eric Baudin, Isabelle Bourdeau, André Lacroix, Paola Loli, Alfredo Berruti, Darko Kastelan, Harm R Haak, Martin Fassnacht, Massimo Terzolo
What Is the Optimal Duration of Adjuvant Mitotane Therapy in Adrenocortical Carcinoma? An Unanswered Question. Journal of personalized medicine 11 (4) (2021)
Elisa Rossini, Edoardo Giacopuzzi, Fabrizio Gangemi, Mariangela Tamburello, Deborah Cosentini, Andrea Abate, Marta Laganà, Alfredo Berruti, Salvatore Grisanti, Sandra Sigala
Estrogen-Like Effect of Mitotane Explained by Its Agonist Activity on Estrogen Receptor-α. Biomedicines 9 (6) (2021)
Salvatore Grisanti, Deborah Cosentini, Marta Laganà, Antonella Turla, Alfredo Berruti
Different management of adrenocortical carcinoma in children compared to adults: is it time to share guidelines? Endocrine 74 (3) (2021)
Andrea Abate, Elisa Rossini, Sara Anna Bonini, Martina Fragni, Deborah Cosentini, Guido Alberto Massimo Tiberio, Diego Benetti, Constanze Hantel, Marta Laganà, Salvatore Grisanti, Massimo Terzolo, Maurizio Memo, Alfredo Berruti, Sandra Sigala
Cytotoxic Effect of Trabectedin In Human Adrenocortical Carcinoma Cell Lines and Primary Cells. Cancers 12 (4) (2020)
Vittoria Basile, Puglisi Soraya, Anna Calabrese, Anna Pia, Paola Perotti, Alfredo Berruti, Giuseppe Reimondo, Massimo Terzolo
Unwanted Hormonal and Metabolic Effects of Postoperative Adjuvant Mitotane Treatment for Adrenocortical Cancer. Cancers 12 (9) (2020)
Guido Alberto Massimo Tiberio, Vittorio Ferrari, Zeno Ballarini, Giovanni Casole, Marta Laganà, Michele Gritti, Elisa Arici, Salvatore Grisanti, Riccardo Nascimbeni, Sandra Sigala, Alfredo Berruti, Arianna Coniglio
Hyperthermic Intraperitoneal Chemotherapy for Primary or Recurrent Adrenocortical Carcinoma. A Single Center Study. Cancers 12 (4) (2020)
Carla Fornaro, Maria Piubeni, Valeria Tovazzi, Deborah Cosentini, Maria Gelmi, Gabriella Rota, Barbara Berta, Wilma Barucco, Eleonora Lombardi, Luisa Moles, Tiziana Faustini, Tiziana Fettolini, Paolo Motta, Vittorio D Ferrari, Alfredo Berruti, Elisabetta Conti
Eight-week interval in flushing and locking port-a-cath in cancer patients: A single-institution experience and systematic review. European journal of cancer care 28 (2) (2018)